ACM
TSVT

Altium Capital Management’s 2seventy bio TSVT Stock Holding History

Altium Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-140,000
Closed -$2.04M – 131
2022
Q3 		$2.04M Buy
140,000
+57,000
+69% +$846K 0.75% 53
2022
Q2 		$1.1M Sell
83,000
-32,000
-28% -$436K 0.44% 71
2022
Q1 		$1.96M Buy
+115,000
New +$1.95M 0.66% 57

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Altium Capital Management's TSVT Position: Q4 2022 in Review

Altium Capital Management sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 140,000 shares — an estimated $2.04M sold.

Altium Capital Management first reported a position in TSVT in Q1 2022 and held it in 3 quarters. The position peaked at $2.04M in Q3 2022. 141 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • Altium Capital Management reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 140,000 2seventy bio shares in Q4 2022, an estimated $2.04M.
  • Altium Capital Management first reported a position in 2seventy bio in Q1 2022 and held it in 3 quarters.
  • Altium Capital Management's 2seventy bio position peaked at $2.04M in Q3 2022.
  • 141 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.